Clene CLNN
NASDAQ CLNN
$4.08 +0.06 (+1.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Clene (CLNN) Return on Equity [ROE] (2021 - 2024)

Updated

Clene (CLNN) recorded Return on Equity [ROE] of -1738.36% in FY2024, down 1142.90 percentage points from -595.47% in FY2023.

Analysis

Clene (CLNN) Return on Equity [ROE] (2021 - 2024) Analysis & Trends

Starting with FY2021, Clene's Return on Equity [ROE] history includes 4 years.

  • Annual Return on Equity [ROE] has declined for three straight years, with a three-year change of -1587.80 percentage points (FY2021 to FY2024).
  • Per Business Quant data, CLNN's Return on Equity [ROE] was -595.47% in FY2023 (-217.57 pp), -377.90% in FY2022 (-227.33 pp) and -150.56% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Clene 52.14 Mn 52.14 Mn 54,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1,620.00%
Mar 31, 2024 -553.01%
Dec 31, 2023 -284.59%
Sep 30, 2023 -188.16%
Jun 30, 2023 -491.91%
Mar 31, 2023 -3,521.94%
Jun 30, 2022 2,129.16%
Mar 31, 2022 228.03%
Dec 31, 2021 -106.55%
API Access

Clene Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLNN&period=max&api_key=YOUR_API_KEY